- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07642570
FILLing Protocols for the Right Bladder Volume at the RIGHT Time (FILLRIGHT) (FILLRIGHT)
FILLing Protocols for the Right Bladder Volume at the RIGHT Time
The goal of this clinical trial is to compare evaluation of oral hydration protocols for the right optimal bladder filling prior to pelvic ultrasound.
The main question it aims to answer is which quantity of water should patiente drink before a pelvic ultrasound.
Woman participants will drink 4 differents quantity of water over 4 differents days:
- Quantity A : 1000 ml in 15 minutes
- Quantity B : 750 ml in 10 minutes
- Quantity C : 500 ml in 5 minutes
- Quantity D : 250 ml in 1 minutes
The order of the hydration protocols will be randomized.
All procedures are performed in the same way:
- Before ingestion of water, the patient should urinate band (the volumen will be measured) an an ultrasound examination will be performed to assess the residual post-void volume
- The patiente drinks water and the time was collected
Every 5 minutes during the procedure :
- A suprapubic ultrasound examination will be performed to assess the bladder filling and to calculate of bladder volume using the standard formula (length × width × height × 0.52)
- The Bladder Sensation Scale (BSS) was collected.
- When the score to BBS reaches 3, the procedure should be stopped and the patiente should urinate band (the volumen will be measured). Then a last ultrasound examination will be performed.
After each procedure, the patiente answer at this question: "On a scale from 1 (very poor) to 10 (excellent), how would you rate the acceptability of ingesting the required hydration volume?"
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Benoit CHIRON, Pr
- Telefonnummer: 06.98.34.71.01
- E-Mail: benoitchiron@yahoo.fr
Studieren Sie die Kontaktsicherung
- Name: Tiphaine MENEZ
- Telefonnummer: 02.30.33.84.60
- E-Mail: tiphaine.menez@chu-brest.fr
Studienorte
-
-
-
Le Relecq-Kerhuon, Frankreich, 2948
- Pr Benoit CHIRON
-
Unterermittler:
- Paul AUJOULAT, Dr
-
Kontakt:
- Benoit CHIRON, Pr
- Telefonnummer: 02 98 40 19 21
- E-Mail: benoitchiron@yahoo.fr
-
Hauptermittler:
- Benoit CHIRON, Pr
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Adult woman
- Nulliparous woman
- Affiliated with a social security system
Exclusion Criteria:
- Pregnant woman
- Menopause
- History of hysterectomy
- Absence of uterus
- Symptoms of urinary tract infection (macroscopic hematuria, burning during urination, pollakiuria)
- Overactive bladder defined by the clinical question: "Do you have an urgent need to urinate, difficult to control, sometimes resulting in leakage?"
- Under legal protection (guardianship, conservatorship)
- Refusal to participate
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Hydratation protocols
Woman participants will drink 4 differents quantity of water over 4 differents days:
The order of the hydration protocols will be randomized. |
Woman participants will drink 1000 ml in 15 minutes. Before ingestion of water, an ultrasound examination will be performed to assess the residual post-void volume. Before ingestion of water, a suprapubic ultrasound examination will be performed to assess the bladder filling, and calculation of bladder volume using the standard formula (length × width × height × 0.52). During ultrasound examination, a self-assessment of urinary sensitivity using the Bladder Sensitivity Scale (BSS) will be conducted. Woman participants will drink 750 ml in 10 minutes. Before ingestion of water, an ultrasound examination will be performed to assess the residual post-void volume. Before ingestion of water, a suprapubic ultrasound examination will be performed to assess the bladder filling, and calculation of bladder volume using the standard formula (length × width × height × 0.52). During ultrasound examination, a self-assessment of urinary sensitivity using the Bladder Sensitivity Scale (BSS) will be conducted. Woman participants will drink 500 ml in 5 minutes. Before ingestion of water, an ultrasound examination will be performed to assess the residual post-void volume. Before ingestion of water, a suprapubic ultrasound examination will be performed to assess the bladder filling, and calculation of bladder volume using the standard formula (length × width × height × 0.52). During ultrasound examination, a self-assessment of urinary sensitivity using the Bladder Sensitivity Scale (BSS) will be conducted. Woman participants will drink 250 ml in 1 minutes. Before ingestion of water, an ultrasound examination will be performed to assess the residual post-void volume. Before ingestion of water, a suprapubic ultrasound examination will be performed to assess the bladder filling, and calculation of bladder volume using the standard formula (length × width × height × 0.52). During ultrasound examination, a self-assessment of urinary sensitivity using the Bladder Sensitivity Scale (BSS) will be conducted. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Bladder volume
Zeitfenster: Inclusion
|
The cumulative duration, for each protocol, during which two conditions are met:
Each score represents what the patient feels at a specific moment: 0: No sensation - The bladder is empty, or the patient feels absolutely nothing.
|
Inclusion
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Bladder volume progression
Zeitfenster: Inclusion
|
For each protocol, the average curve of bladder volume progression will plott.
A suprapubic ultrasound examination will be performed every 5 minutes during the procedure to calculate of bladder volume using the standard formula (length × width × height × 0.52).
|
Inclusion
|
|
Bladder Sensation Scale progression
Zeitfenster: Inclusion
|
For each protocol, the average curve of Bladder Sensation Scale (BSS) progression will plott. The BSS is a medical tool used to evaluate and quantify how a patient perceives bladder fullness. The scale typically ranges from 0 to 4 . Each score represents what the patient feels at a specific moment: 0: No sensation - The bladder is empty, or the patient feels absolutely nothing.
|
Inclusion
|
|
Correlation between filling rate and the BSS scale
Zeitfenster: Inclusion
|
Correlation between filling rate (a suprapubic ultrasound examination will be performed to assess the bladder filling every 5 minutes during the procedure) and the Bladder Sensation Scale will be assessed at the same time.
|
Inclusion
|
|
Minimum time
Zeitfenster: Inclusion
|
Determination, for each protocol, of the minimum time required to achieve a bladder volume ≥ 150 ml in all participants (a suprapubic ultrasound examination will be performed to assess the bladder filling every 5 minutes during the procedure).
|
Inclusion
|
|
Bladder volume
Zeitfenster: Inclusion
|
Absolute and relative difference between the actual urine volume and the ultrasound-estimated volume just before voiding at the end of the procedure, adjusted after ultrasound estimation of post-void residual urine. Before ingestion of water, the patient should urinate band (the volumen will be measured) an an ultrasound examination will be performed to assess the residual post-void volume. When the BSS score reaches 3, the procedure should be stopped and the patiente should urinate band (the volumen will be measured). Then a last ultrasound examination will be performed. |
Inclusion
|
|
Acceptability for each protocol
Zeitfenster: Inclusion
|
Cumulative acceptability score for each protocol on a scale from 1 to 10. Response to the question: "On a scale from 1 (very poor) to 10 (excellent), how would you rate the acceptability of ingesting the required hydration volume?"
|
Inclusion
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 29BRC25.0437 - FILLRIGHT
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .